Loading data for CTMX — first visit, this takes a few seconds.
CytomX Therapeutics Inc. (CTMX)
NasdaqGS: CTMX
· 실시간 가격 · USD
3.33
+0.04 (1.22%)
종가 기준: Aug 21, 2026, 8:00 PM
3.28
+0.00%
애프터마켓: 7:30 PM
주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.
CytomX Therapeutics Inc.(CTMX) 주가, 분석 및 데이터
1.22% (1D)
데이터 없음
CTMX 소개
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increa...
전체 기업 정보재무 실적
2025년 CytomX Therapeutics의 매출은 76.2M로, 전년 138.1M 대비 -44.82% 감소했습니다. 순이익은 -17.37M로, -154.5% 감소했습니다.
재무제표
